Role of Alanine Racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.

Nakatani, Y .; Opel-Reading, H.K .; Merker, M .; Machado, D .; Andres, S .; Kumar, S.S .; Moradigaravand, D .; Coll, F .; Perdigão, J .; Portugal, I .; Schön, T .; Nair, D .; Uma Devi, K.R .; Kohl, T.A .; Beckert, P .; Clark, T.G .; Maphalala, G .; Khumalo, D ,; Diel, R .; Klaos, K .; Aung, H.L .; Cook, G.M .; Parkhill, J .; Peacock, S.J .; Swaminathan, S .; Viveiros, M .; Niemann, S .; Krause, K.L .; Köser, C.U .

Antimicrobial Agents and Chemotherapy; 2017; 61: 1-5.

Abstract: A screening of more than 1,500 drug-resistant strains of Mycobacterium tuberculosis revealed evolutionary patterns characteristic of positive selection for three alanine racemase (Alr) mutations. We investigated these mutations using molecular modeling, in vitro MIC testing, as well as direct measurements of enzymatic activity, which demonstrated that these mutations likely confer resistance to D-cycloserine.


Keywords: Mycobacterium tuberculosis; cycloserine; alanine racemase




Back to List of publications / Home